BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19922930)

  • 1. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing.
    Bretagne JF; Hamonic S; Piette C; Manfredi S; Leray E; Durand G; Riou F
    Gastrointest Endosc; 2010 Feb; 71(2):335-41. PubMed ID: 19922930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplasia detection rates after positive fecal occult blood test results are not affected by endoscopy center: a population-based study.
    Bretagne JF; Hamonic S; Piette C; Manfredi S; Mallard G; Durand G; Riou F
    Gastrointest Endosc; 2011 Jul; 74(1):141-7. PubMed ID: 21704812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
    Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
    Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
    Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
    Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
    Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M
    Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.
    Ventura L; Zappa M; Carreras G; Ciatto S; Grazzini G
    Tumori; 2011; 97(5):547-50. PubMed ID: 22158481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval cancer after colonoscopy in the Austrian National Screening Programme: influence of physician and patient factors.
    Waldmann E; Penz D; Šinkovec H; Heinze G; Rinner C; Jiricka L; Majcher B; Hinterberger A; Trauner M; Ferlitsch M
    Gut; 2021 Jul; 70(7):1309-1317. PubMed ID: 33023903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in quality of screening colonoscopy in Austria.
    Waldmann E; Gessl I; Sallinger D; Jeschek P; Britto-Arias M; Heinze G; Fasching E; Weiss W; Gschwantler M; Trauner M; Ferlitsch M
    Endoscopy; 2016 Dec; 48(12):1102-1109. PubMed ID: 27576182
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death.
    Kaminski MF; Wieszczy P; Rupinski M; Wojciechowska U; Didkowska J; Kraszewska E; Kobiela J; Franczyk R; Rupinska M; Kocot B; Chaber-Ciopinska A; Pachlewski J; Polkowski M; Regula J
    Gastroenterology; 2017 Jul; 153(1):98-105. PubMed ID: 28428142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
    Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
    Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer.
    Baldacchini F; Bucchi L; Giuliani O; Mancini S; Ravaioli A; Vattiato R; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Mezzetti F; Sassoli de Bianchi P; Ferretti S; Falcini F;
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2361-2369. PubMed ID: 32827723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
    Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors associated with colorectal flat adenoma detection.
    Nicolás-Pérez D; Parra-Blanco A; Gimeno-García AZ; Ortega-Sánchez JA; Carrillo-Palau M; Jiménez-Sosa A; Quintero-Carrion E
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):302-8. PubMed ID: 23169312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in polyp detection rates at screening colonoscopy.
    Imperiale TF; Glowinski EA; Juliar BE; Azzouz F; Ransohoff DF
    Gastrointest Endosc; 2009 Jun; 69(7):1288-95. PubMed ID: 19481649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a quarterly report card on colonoscopy quality measures.
    Kahi CJ; Ballard D; Shah AS; Mears R; Johnson CS
    Gastrointest Endosc; 2013 Jun; 77(6):925-31. PubMed ID: 23472996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Tytgat KM; Dees J; Mathus-Vliegen EM; Kuipers EJ; Fockens P; van Leerdam ME; Dekker E
    Gastrointest Endosc; 2013 Apr; 77(4):617-23. PubMed ID: 23321338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test.
    Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A
    Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.